Plain-English translation of NCT06578195 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The ASSESS ALL ALS study is a large research project funded by the National Institutes of Health that follows people with ALS and healthy control participants for two years. Researchers will collect blood samples, medical history, voice recordings, and other measurements to identify biological markers—early warning signs or disease indicators—that could help doctors understand ALS better and develop new treatments in the future.
Doctors still don't fully understand what causes ALS or how to slow it down. By collecting and studying samples and information from many patients over time, researchers hope to discover new clues about how the disease develops and progresses, which could eventually lead to better treatments.
You likely qualify if…
You likely don't qualify if…
Depending on where you live, you can participate in person at one of 35 study sites across the country or remotely via video call. You'll have visits every four months where researchers collect blood samples, and you'll complete monthly surveys and voice recordings from home. The entire study lasts two years, and if you visit a clinic in person, you may have the option to provide additional spinal fluid samples.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States